Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: How will these market conditions affect PTSC?

Lets hope Crossflo has enough cash coming in to fund their own operations. I think I read somewhere that they have 25 employees. That could potentially be a drain on our cash reserves. I also read somewhere that they have 20 million coming in annually from operations. I don't know how much debt they have, or if that revenue was residual or one time payments. If one time payments they could be in the same boat as PTSC.

Comments welcome, though not expected.



Share
New Message
Please login to post a reply